Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

New therapies are being developed that target integrin pathways to treat various diseases.

Drug repurposing shows promise for treating many medical conditions.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.